REMAB THERAPEUTICS
RemAb Therapeutics is a developer of polymeric glycoconjugates molecule designed to remove antibodies and treat nosocomial infections. The company's technology aims to develop polymeric glycoconjugates to eliminate non-neutralizing natural antibodies that interfere with the natural response of the immune system and favor pathogen growth, providing patients with a new way of treating and preventing various pathologies.
REMAB THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2018-04-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.remabtx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
71.43 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - RemAb Therapeutics
EIT Health
EIT Health investment in Grant - RemAb Therapeutics
Official Site Inspections
http://www.remabtx.com
- Host name: ns1941.webempresa.eu
- IP address: 213.158.86.53
- Location: Italy
- Latitude: 43.1479
- Longitude: 12.1097
- Timezone: Europe/Rome
